XTalks

MAY 13, 2021

A recent report by Market Watch, based on data from a survey conducted by Hub Entertainment Research in November 2020, shows that the proportion of US consumers who said they were watching a lot more TV than they did prior to the pandemic remains unchanged since July 2020. And this trend doesn’t seem to be letting up any time soon.

Insulin 104

Insulin Marketing Branding Drugs 104

Pharmaceutical Technology

JULY 15, 2022

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328

Insulin Manufacturing Contract Manufacturing Production 328

Pharmaceutical Technology

JANUARY 31, 2023

While insulin price caps will begin this year, larger effects will be delayed until 2026 – when the US federal government will be allowed to negotiate Medicare prices and demand rebates from drug companies that price gouge. That leaves three years for pharma companies to prepare.

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

pharmaphorum

NOVEMBER 22, 2022

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter for marketing and patients who utilise it to engage with their medical communities. The post Elon Musk, pharma, and the future of Twitter appeared first on. How to react.

Branding 59

Branding Pharma Companies Marketing Insulin 59

XTalks

FEBRUARY 21, 2024

Recently, Eli Lilly revealed promising results from a mid-stage trial, indicating that its popular drug, tirzepatide (marketed as Zepbound and Mounjaro for weight loss and diabetes, respectively), may be an effective treatment for the fatty liver disease metabolic dysfunction-associated steatohepatitis (MASH).

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

pharmaphorum

JUNE 2, 2022

Evaluate Pharma’s recent Orphan Drug Report subtitled its overview of the market ‘Niche no longer.’ The report estimates that the orphan drug market will grow twice as fast as the non-orphan market, with a 2021 to 2026 compound annual growth rate of 12%. The price is right. Raising questions. Reaching a compromise.

Drugs 52

Drugs Sales Marketing Development 52

Pharma Marketing Network

OCTOBER 27, 2020

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. Robin welcome to the Pharma marketing podcast and thanks for joining us today.

Insulin 52

Insulin Marketing Doctor Doctors 52

Pharma Marketing Network

OCTOBER 27, 2020

Don ( PMN): Hello everyone welcome to the Pharma marketing podcast. She has been involved with over 20 early stage startups working on cutting edge technology in healthcare; biotech, pharma, med device, and digital health. Robin welcome to the Pharma marketing podcast and thanks for joining us today.

Insulin 52

Insulin Doctor Doctors Marketing 52

The Pharma Data

MAY 14, 2021

You won’t believe the marketing techniques of some food companies, who have convinced the public that certain foods are healthy when in fact they are just the opposite.We’ll expose the truth behind these food products and how you can replace them with far healthier and just as, if not more, delicious options.

Doctor 52

Doctor Doctors Insulin Production 52

Delveinsight

AUGUST 25, 2021

Pharmaceutical companies may deal in both generic and brand-name drugs as well as medical devices. They are governed by a number of rules and regulations that govern drug patenting, testing, safety, efficacy, and marketing. . The global healthcare spending in 2020 was USD 8.3 trillion and it is expected to increase to USD 8.8

Vaccination 98

Vaccination Vaccine Drugs Sales 98

pharmaphorum

JUNE 10, 2021

The fundamental misconception among the public, the media and even some lawmakers is that higher drug list prices are the result of drug manufacturers being in a monopolistic position to endlessly raise prices on critical drugs like insulin and then rake in big profits. What’s Next: How Should Pharma Companies Respond?

Manufacturing 105

Manufacturing Drugs Pharma Companies Pharmacy 105

pharmaphorum

SEPTEMBER 1, 2020

Previously a centre of the trade in textiles and dyes, Swiss manufacturers gradually began to realise their dyestuffs had antiseptic and other properties and began to market them as pharmaceuticals, in contrast to the origin in pharmacies of other enterprises. An advert for Bayer’s Aspirin from the early 20th century.

Medicine 145

Medicine Insulin Drugs Pharmacy 145

STAT News

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. Two

Insulin 96

Insulin Pharmacy Pharma Companies Drugs 96

XTalks

JUNE 14, 2024

The $40 million will come from the Venture Ontario Fund, which is dedicated to helping Ontario life sciences companies and biomanufacturers innovate, grow and compete in global markets. The province takes pride in being home to the discovery of insulin and stem cells, and the largest life sciences jurisdiction in Canada.

Life Science 52

Life Science Insulin Research Manufacturing 52

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. Jonathan was in his late 40s and came into my pharmacy to pick up his insulin for his diabetes, when he told me about his father. It’s all about the bottom line, at any cost.

Production 52

Production Pharmacy Doctor Doctors 52

World of DTC Marketing

DECEMBER 7, 2021

LEAD IN: Pharma companies are a business and have the right to make money but at what cost and how much is enough? There is no debate that today’s pharmaceutical companies have helped us lead longer and better lives, but they have made their shareholders and CEOs a lot of money in the process. Is this acceptable?

Vaccination 222

Vaccination Vaccine Insulin Pharma Companies 222

XTalks

SEPTEMBER 11, 2023

The first ten drugs to undergo Medicare drug price negotiations were chosen based on criteria determined by Medicare, which include that they be sold in pharmacies, not have significant generic competition and have been on the market for at least nine years (13 years for more complex biologics). billion Medicare enrollees who used drug: 3.7

Drugs 108

Drugs Sales Insulin Life Science 108

XTalks

DECEMBER 3, 2024

Diabetes affects millions worldwide, and the pharmaceutical market is responding with treatments that not only improve glycemic control but also address cardiovascular and kidney-related complications, offering holistic management for patients. The company is targeting revenue of $40.4 billion to $41.6

Sales 103

Sales Insulin FDA Approval Drugs 103

pharmaphorum

NOVEMBER 4, 2021

That would only be possible years after they have lost market exclusivity however – nine years for small-molecule drugs and 12 years for biologics – and would take place in a stepwise fashion. The compromise deal does not sit well with industry body PhRMA however.

Drugs 52

Drugs Insulin Medicine Marketing 52

World of DTC Marketing

JUNE 16, 2021

The pharma industry has been riding a wave of public approval since they developed a vaccine to fight COVID-19, but that goodwill is going to be short lived thanks, in part, to the $56,000 price tag of Biogen’s new drug and insulin that too many people still can’t afford.

Drugs 180

Drugs Branding Medicine Insulin 180

World of DTC Marketing

DECEMBER 16, 2021

(Axios) Second-quarter results are still pouring in, but so far, a vast majority of health care companies are reporting profits that many people assumed would not have been possible as the pandemic continued. Drug sales fell across many pharma companies but cutting administrative and research costs kept earnings at industry highs.

Insulin 205

Insulin Pharma Companies Drugs Branding 205

World of DTC Marketing

DECEMBER 14, 2021

WHAT’S HAPPENING: In the Build Back Better bill , Democrats are actually proposing limiting insulin prices to $35 a month but Republicans can’t have any of that. PhRMA spent pharma’s money well and bought some politicians while people who need insulin are suffering.

Insulin 184

Insulin Branding Drugs Production 184

XTalks

FEBRUARY 14, 2024

On the other hand, Republican senators largely defended the CEOs and the free market. They also blamed pharmacy benefit managers (PBMs), third-party companies that serve as pharma middlemen, who select which drugs receive insurance coverage and charge drug companies rebates and fees for covering them.

Drugs 52

Drugs Insulin Pharmacy Development 52